lanzo 30 mg rakeet oraalisuspensiota varten
wyeth lederle nordiska ab - lansoprazolum - rakeet oraalisuspensiota varten - 30 mg - lansopratsoli
mylotarg
wyeth europa ltd - gemtutsumab-ozogamisiini - leukemia, myeloidi, akuutti - antineoplastiset aineet - re-induktio hoito cd33-positiivisia aml aikuisten potilaiden ensimmäinen relapsivaihe, jotka eivät ole ehdokkaita muissa intensiivinen uudelleen induktio solunsalpaajahoito (e. korkea-annos ara-c) ja sen on täytettävä ainakin yksi seuraavista kriteereistä: kesto ensimmäisen remission 60 vuotta.
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.
methotrexate injektiokuiva-aine
wyeth-ayerst lederle inc american cyanamid company - methotrexatum natricum - injektiokuiva-aine - metotreksaatti
leucovorin 3 mg/ml injektioneste
wyeth-ayerst lederle inc american cyanamid company - kalsium folinas - injektioneste - 3 mg/ml - kalsiumfolinaatti
methotrexate 2.5 mg/ml injektioneste
wyeth-ayerst lederle inc american cyanamid company - methotrexatum - injektioneste - 2.5 mg/ml - metotreksaatti
vancoled 500 mg infuusiokuiva-aine
wyeth-ayerst lederle inc american cyanamid company - vancomycini hydrochloridum - infuusiokuiva-aine - 500 mg - vankomysiini
diamox 250 mg tabletti
wyeth lederle nordiska ab - acetazolamidum - tabletti - 250 mg - asetatsolamidi
aureomycin 1 % silmävoide
wyeth lederle nordiska ab - chlortetracyclini hydrochloridum - silmävoide - 1 % - klooritetrasykliini
ledermycin 300 mg tabletti
wyeth lederle nordiska ab - demeclocyclini hydrochloridum - tabletti - 300 mg - demeklosykliini